BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B

e vs e

Mechanistic comparison of e 64 and e 64c based on molecular target overlap from BindingDB and ChEMBL binding affinity data.

3
Shared Targets
38%
Jaccard Similarity
37%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.

Evidence Comparison

e 64
Evidence Score
0
PubMed Studies
View full profile →
e 64c
Evidence Score
0
PubMed Studies
View full profile →

Target Overlap

e and e share 3 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.375 means 38% of the combined target set is bound by both compounds. The IDF-weighted score of 0.365 accounts for non-specific binding to metabolic enzymes.

Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.

Frequently Asked Questions

What do e and e have in common?
e and e share 3 molecular targets with a Jaccard similarity of 38%. Both bind overlapping sets of proteins based on BindingDB and ChEMBL binding affinity data.
Can e and e be combined?
e and e share 3 molecular targets, suggesting potential pathway overlap. Combination use should be evaluated with a qualified healthcare professional. BiohacksAI does not provide medical advice.
Which has more research: e or e?
In the BiohacksAI corpus: e has 0 PubMed-indexed studies, e has 0 studies.

Related Comparisons

Similar to e

e vs calpeptin4 targetse vs cyano4 targetse vs balicatib4 targetse vs odanacatib4 targetse vs leupeptin5 targets

Similar to e

e vs calpeptin2 targetse vs aloxistatin2 targetse vs mg2 targetse vs leupeptin2 targets
View full e profile →View full e profile →Browse all substances →